Seaweed Oligosaccharide Modification Service
Inquiry

Seaweed Oligosaccharide Modification Service

By precisely introducing new functional groups or altering existing ones, CD BioGlyco transforms natural seaweed oligosaccharides into novel, high-value derivatives with enhanced or entirely new biological activities. This chemical and enzymatic tailoring is the key to unlocking the next generation of marine-derived therapeutics and functional ingredients, enabling our clients to accelerate their R&D pipelines and gain a competitive edge.

Key Technologies

  • Advanced Chemical Synthesis

Our expertise covers diverse reaction chemistries, including regioselective sulfation, precise acetylation, and robust coupling reactions for conjugation. Crucially, we employ orthogonal protection group strategies to selectively target specific hydroxyl or amine groups on the carbohydrate backbone, ensuring that the desired modification occurs at the exact location required for the targeted function.

  • High-Resolution Structural Characterization

We employ gold-standard techniques like high-performance liquid chromatography (HPLC), gel permeation chromatography (GPC) for molecular weight, nuclear magnetic resonance (NMR) spectroscopy for linkage and group confirmation, and mass spectrometry (MS) for detailed structural mapping.

Precision Seaweed Oligosaccharide Modification for Bio-Functional Excellence

CD BioGlyco provides a comprehensive and technically demanding suite of seaweed oligosaccharide modification services, specifically designed to fine-tune physicochemical and biological properties for highly specialized applications. Our commitment to high purity and structural verification allows our clients to confidently advance their most challenging research and product development projects.

(CD BioGlyco)

The degree and pattern of sulfation are critical determinants of the biological activity of many marine oligosaccharides (e.g., anticoagulant, anti-inflammatory, and viral inhibition properties). We offer controlled modification services to precisely introduce sulfate groups (SO3) at specific positions or to adjust the overall degree of sulfation (DS) to optimize bioactivity. Conversely, controlled desulfation can modulate binding affinity and toxicity.

The introduction of acetyl (-COCH3) or carboxymethyl (-CH2COOH) groups alters the charge, solubility, and receptor recognition profile of the oligosaccharide. Acetylation is frequently used to enhance cell permeability or modulate immune responses. Carboxymethylation significantly improves water solubility and stability, making the derivative suitable for broader aqueous formulations.

(CD BioGlyco)

(CD BioGlyco)

For mechanistic studies, cellular tracking, and diagnostic development, we conjugate seaweed oligosaccharides with a variety of labels. This includes FITC, TRITC, biotin, etc. Our conjugation chemistry ensures minimal impact on the oligosaccharide's core structure while achieving a stable and high-efficiency labeling yield.

This specialized service is crucial for developing amphiphilic derivatives, often required for drug delivery systems, membrane targeting, or emulsifying agents. By grafting hydrophobic groups, such as long-chain fatty acids (e.g., palmitoyl, stearoyl) or alkyl chains, we develop oligosaccharide-lipid conjugates with improved micelle formation, enhanced cell membrane interaction, or controlled release kinetics.

(CD BioGlyco)

Workflow

1. Initial Consultation & Design

This stage involves a deep discussion with our client to define the target application, desired biological activity, the starting oligosaccharide material, and the specific modification required. Our scientists translate these objectives into a detailed molecular design plan, including the synthesis strategy and analytical benchmarks.

2. Oligosaccharide Preparation

Starting with raw seaweed material or existing oligosaccharide stocks, we employ optimized extraction and enzymatic or chemical hydrolysis techniques to isolate and purify the specific oligosaccharide backbone. CD BioGlyco utilizes advanced purification methods to ensure the starting material meets the highest purity standards before modification.

3. Targeted Chemical/Enzymatic Modification

This is the core synthesis stage where the defined functional groups are introduced. This involves one or more complex, multi-step reactions, such as the selective addition of sulfate groups, the incorporation of acetyl moieties, or the attachment of fluorescent tags. Reactions are meticulously optimized for regioselectivity and high yield.

4. Purification and Isolation of Derivative

Following the reaction, the crude modified product is subjected to a series of high-end purification steps. This is often the most critical step for achieving pharmaceutical-grade purity, utilizing preparative chromatography (e.g., ion-exchange, size exclusion) to isolate the final, homogenous modified oligosaccharide derivative.

5. Rigorous Structural Confirmation

Every batch of the modified oligosaccharide undergoes comprehensive quality control (QC). Using a battery of advanced analytical tools (NMR, HPLC-MS), we confirm the exact molecular weight, the location of the modification, the degree of substitution, and the overall purity, ensuring it matches the initial design specification.

6. Final Report & Delivery

The client receives the highly pure, custom-modified seaweed oligosaccharide along with a comprehensive data package, including all raw and analyzed QC reports, the detailed synthesis protocol, and certificate of analysis.

Publication Data

DoI: 10.3390/md14030042

Journal: Marine Drugs

IF: 5.4

Published: 2016

Results: This review focuses on three sulfated seaweed polysaccharides—carrageenan (red algae), fucoidan (brown algae), and ulvan (green algae)—as multifunctional materials for drug delivery. It outlines their structural features, extraction methods, and physicochemical properties, along with biological activities like anticoagulant and antiviral effects. Key applications include particulate carriers (nano/microparticles), hydrogels, beads, films, and matrix tablets, with carrageenan the most extensively studied and ulvan the least explored. These polysaccharides enable controlled drug release, biocompatibility, and functionalization via sulfate groups and hydroxyl moieties. The review also discusses their potential for targeted delivery, particularly macrophage targeting through interactions with cell surface receptors.

Fig.1 Carrageenan gel formation.Fig.1 Scheme of carrageenan gel formation. (Cunha & Grenha, 2016)

Applications

  • Drug Discovery and Development
    Designing novel oligosaccharide-based drugs with enhanced target specificity for applications like anticoagulation, anti-cancer therapy, and antiviral agents.
  • Advanced Drug Delivery Systems
    Creating amphiphilic derivatives for use as stabilizers, encapsulating agents, or targeted ligands in nanoparticle formulations and liposomes, enabling better delivery of small molecules or proteins.
  • Nutraceutical Development
    Modifying oligosaccharides to optimize prebiotic activity or enhance antioxidant and anti-inflammatory properties, creating superior functional ingredients.
  • Cosmetics and Dermatology
    Utilizing derivatives with improved moisturizing, film-forming, or anti-aging properties, often achieved through enhanced solubility (carboxymethylation) or specific dermal targeting.

Advantages

  • Glyco-Specificity Control
    Our proprietary enzymatic and chemical services allow for regioselective modification—ensuring the functional group is placed exactly where you need it.
  • High Purity
    We consistently deliver modified oligosaccharides with purities exceeding the industry standard, typically >95% and often higher, validated by our rigorous QC protocols.
  • Comprehensive Analytical Support
    Our clients receive a complete data package, including validates the structural integrity and modification efficiency.
  • Flexible Scalability
    Our advanced synthesis and purification capabilities ensure seamless, high-quality scale-up without compromising structural integrity.

Frequently Asked Questions

How does chemical modification actually enhance bioactivity?

Modification, such as precision sulfation or acetylation, subtly changes the molecule's charge density and 3D structure. This significantly improves its ability to bind to specific biological targets (e.g., receptors, enzymes), thereby increasing potency and therapeutic specificity. We design the modification to maximize the desired effect.

Can you work with a specific, proprietary seaweed oligosaccharide I already have?

Absolutely. We are fully equipped to utilize client-supplied starting material, provided it meets our QC standards for initial purity and structural confirmation. We can also source and prepare a variety of starting materials for you.

Customer Review

"We approached CD BioGlyco with a requirement for a very specific, regioselectively sulfated alginate oligosaccharide for our anti-inflammatory study. Their team delivered a product with over 98% purity and the exact degree of substitution we requested."

- A.P., Senior Research Scientist

"The modification service for our fucoidan oligosaccharide was a game-changer. The hydrophobic grafting they performed dramatically improved the stability of our nanoparticle formulation. The team was highly consultative, helping us troubleshoot the optimal fatty acid chain length."

- J.C., R&D Director

"Starting with milligram quantities and needing to scale up to over 100 grams for an animal study, CD BioGlyco maintained impeccable quality control throughout."

- P.S., Senior Research Scientist

Associated Services

CD BioGlyco is your essential partner in transforming natural marine bioactives into highly optimized, functional molecules. Please feel free to contact us to discuss your specific requirements, receive a detailed consultation, and start designing your custom modified seaweed oligosaccharide.

Reference

  1. Cunha, L.; Grenha, A. Sulfated seaweed polysaccharides as multifunctional materials in drug delivery applications. Marine Drugs. 2016, 14(3): 42. (Open Access)
For research use only. Not intended for any clinical use.

Related Services

Contact Us
Top